SOMAREALITY

SOMAREALITY website preview
pre-seed medtech Wien, AT 3 sources
Own this company? Claim the page to unlock editing and verified-owner badge.

SOMAREALITY specializes in developing eye tracking-based digital biomarkers to provide real-time cognitive insights and monitor cognitive processes.

Classification

Wien AT pre-seed medtech saas b2b aiiot HealthAIAnalyticsVirtual Reality

Profile

Tech stack
eye tracking technology

Funding

Latest round
round_type=seed
Business model
💡 Value Proposition

Delivers effortless, real-time cognitive insights via eye-tracking-based digital biomarkers to unlock human potential.

👥 Customer Segments

Industries seeking to enhance human performance and monitor cognitive processes; specific buyer profiles not detailed.

💰 Revenue Model

Information insufficient

📡 Channels

Information insufficient

🤝 Key Partnerships

Information insufficient

⚖️ Cost Structure

Primarily driven by R&D for advanced eye-tracking technology and neuropsychological expertise.

🏗️ Key Resources

Expert team of neuropsychologists and eye-tracking technology specialists dedicated to pioneering cognitive tech.

⚙️ Key Activities

Developing eye-tracking-based digital biomarkers and providing cognitive insights for real-time monitoring.

💬 Customer Relationships

Information insufficient

Strategic analysis
🏁 Competitive landscape

Competes in cognitive technology by offering real-time digital biomarkers; specific competitors not identified in snippets.

🎯 Market pains

Need for real-time understanding and monitoring of cognitive processes to enhance human performance.

💎 Improvement suggestions
  • Diversify Revenue with a “Pay-per-Insight” model - Offer a micro-transaction API that charges per cognitive-load event for developers who
🛡️ Credibility notes
  • Source triangulation - The analysis pulls from the company’s own “About Us”, “Use Cases”, and recent interview articles, ensuring the des
Team
CEO
Co-founder
Investors

No investors recorded yet.

Sources & references

Web verified · 3 sources
Enriched 18 Jun 2026